Posted by Defense World Staff on Feb 14th, 2026
Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) – Equities researchers at HC Wainwright issued their Q4 2026 earnings estimates for Viking Therapeutics in a note issued to investors on Thursday, February 12th. HC...
More of this article »